Aurealis Pharma

About:

Aurealis Pharma is a biopharmaceutical company.

Website: http://www.aurealispharma.com

Twitter/X: aurealispharma

Top Investors: Business Finland, Business Finland, Finnvera Venture Capital

Description:

Aurealis Pharma is a biopharmaceutical company aiming at developing ground-breaking medicines for the treatment of cancer and chronic wounds. They are dedicated in the R&D of gene and cell based therapies, as well as the development of new active molecules by computational modeling of nature derived compounds. Their key strategy is to perform outstanding interdisciplinary R&D and to implement these into new business models. They are actively seeking for collaborations with pharmaceutical companies, academic research institutions and pre-clinical CROs.

Total Funding Amount:

13.4M CHF

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Kuopio, Eastern Finland, Finland

Founded Date:

2010-04-01

Founders:

Dirk Weber, Markus forsberg, Thomas wirth

Number of Employees:

1-10

Last Funding Date:

2019-02-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai